{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:55:23Z","timestamp":1790153723349,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["\/2023\/217"],"award-info":[{"award-number":["\/2023\/217"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EMR\/2017\/002140"],"award-info":[{"award-number":["EMR\/2017\/002140"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EMR\/2017\/001183"],"award-info":[{"award-number":["EMR\/2017\/001183"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.bioorg.2024.107294","type":"journal-article","created":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T22:41:46Z","timestamp":1710715306000},"page":"107294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Bis-arylidene oxindoles for colorectal cancer nanotherapy"],"prefix":"10.1016","volume":"146","author":[{"given":"Tithi","family":"Bhattacharyya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanushree","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debojyoti","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanta S.","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajkumar","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2024.107294_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-022-01294-4","article-title":"Exploring immunotherapy in colorectal cancer","volume":"15","author":"Weng","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107294_b0010","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2010.01.058","article-title":"Inflammation and colon cancer","volume":"138","author":"Terzi\u0107","year":"2010","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.bioorg.2024.107294_b0015","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1136\/gutjnl-2014-309086","article-title":"Colorectal cancer screening: a global overview of existing programmes","volume":"64","author":"Schreuders","year":"2015","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.bioorg.2024.107294_b0020","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.drudis.2017.05.006","article-title":"Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives","volume":"22","author":"Banerjee","year":"2017","journal-title":"Drug Discov. Today"},{"issue":"12","key":"10.1016\/j.bioorg.2024.107294_b0025","doi-asserted-by":"crossref","first-page":"e52888","DOI":"10.1371\/journal.pone.0052888","article-title":"PKC activation by resveratrol derivatives with unsaturated aliphatic chain","volume":"7","author":"Pany","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107294_b0030","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/cmdc.201400003","article-title":"Bis-arylidene oxindoles as anti-breast-cancer agents acting via the estrogen receptor","volume":"9","author":"Pal","year":"2014","journal-title":"ChemMedChem"},{"issue":"5\u20136","key":"10.1016\/j.bioorg.2024.107294_b0035","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/1061186X.2018.1433679","article-title":"Oestrogen receptor-mediated liposomal drug delivery for treating melanoma","volume":"26","author":"Ganguly","year":"2018","journal-title":"J. Drug Target."},{"key":"10.1016\/j.bioorg.2024.107294_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106395","article-title":"Cationic lipid-conjugated bis-arylidene oxindole derivatives as broad-spectrum breast cancer-selective therapeutics","volume":"133","author":"Yousuf","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107294_b0045","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/mt.2009.4","article-title":"Selective cancer targeting via aberrant behavior of cancer cell-associated glucocorticoid receptor","volume":"17","author":"Mukherjee","year":"2009","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107294_b0050","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1021\/acs.molpharmaceut.6b00230","article-title":"Glucocorticoid receptor-targeted liposomal codelivery of lipophilic drug and anti-Hsp90 gene: strategy to induce drug-sensitivity, EMT-reversal, and reduced malignancy in aggressive tumors","volume":"13","author":"Mondal","year":"2016","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107294_b0055","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1021\/acs.molpharmaceut.5b00900","article-title":"Development of liposomal formulation for delivering anticancer drug to breast cancer stem-cell-like cells and its pharmacokinetics in an animal model","volume":"13","author":"Ahmad","year":"2016","journal-title":"Mol. Pharm."},{"issue":"28","key":"10.1016\/j.bioorg.2024.107294_b0060","doi-asserted-by":"crossref","first-page":"6804","DOI":"10.1016\/j.biomaterials.2013.05.054","article-title":"Hsp90-targeted miRNA-liposomal formulation for systemic antitumor effect","volume":"34","author":"Pore","year":"2013","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.bioorg.2024.107294_b0065","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1073\/pnas.97.8.3919","article-title":"Glucocorticoids repress NF-\u03baB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell","volume":"97","author":"De Bosscher","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"52","key":"10.1016\/j.bioorg.2024.107294_b0070","doi-asserted-by":"crossref","first-page":"9105","DOI":"10.1016\/S0040-4039(01)02022-6","article-title":"Fluorescent probe for monosaccharides based on a functionalized boron-dipyrromethene with a boronic acid group","volume":"42","author":"DiCesare","year":"2001","journal-title":"Tetrahedron Lett."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107294_b0075","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4103\/1735-5362.213979","article-title":"Factors affecting liposomes particle size prepared by ethanol injection method","volume":"12","author":"Shaker","year":"2017","journal-title":"Research in Pharmaceutical Sciences"},{"key":"10.1016\/j.bioorg.2024.107294_b0080","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.omtm.2020.07.015","article-title":"Barriers and strategies of cationic liposomes for cancer gene therapy","volume":"18","author":"Liu","year":"2020","journal-title":"Molecular Therapy-Methods & Clinical Development"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107294_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3260001","article-title":"Caspases: the executioners of apoptosis","volume":"326","author":"Cohen","year":"1997","journal-title":"Biochem. J"},{"key":"10.1016\/j.bioorg.2024.107294_b0090","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jim.2015.04.025","article-title":"Quantification of apoptosis and necroptosis at the single cell level by a combination of imaging flow cytometry with classical annexin V\/propidium iodide staining","volume":"423","author":"Pietkiewicz","year":"2015","journal-title":"J. Immunol. Methods"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107294_b0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mrrev.2012.08.001","article-title":"In vitro cell migration and invasion assays","volume":"752","author":"Kramer","year":"2013","journal-title":"Mut. Res.\/Rev. Mut. Res."},{"issue":"10","key":"10.1016\/j.bioorg.2024.107294_b0100","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/cbin.11122","article-title":"The influence of serum-supplemented culture media in a transwell migration assay","volume":"43","author":"Omar Zaki","year":"2019","journal-title":"Cell Biol. Int."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107294_b0105","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.3892\/ol.2016.4199","article-title":"Ki-67 expression in luminal type breast cancer and its association with the clinicopathology of the cancer","volume":"11","author":"Yuan","year":"2016","journal-title":"Oncol. Lett."},{"issue":"Suppl 1","key":"10.1016\/j.bioorg.2024.107294_b0110","first-page":"24","article-title":"ki-67 and Topoisomerase IIa proliferation markers in colon adenocarcinoma","volume":"23","author":"Niotis","year":"2018","journal-title":"J. B.U.ON."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107294_b0115","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.18632\/oncotarget.13653","article-title":"Prognostic role of cyclin B1 in solid tumors: a meta-analysis","volume":"8","author":"Ye","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107294_b0120","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","article-title":"Cell cycle control in cancer","volume":"23","author":"Matthews","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.bioorg.2024.107294_b0125","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/antiox8100471","article-title":"Redox-mediated mechanism of chemoresistance in cancer cells","volume":"8","author":"Kim","year":"2019","journal-title":"Antioxidants"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107294_b0130","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","article-title":"ROS in cancer therapy: the bright side of the moon","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bioorg.2024.107294_b0135","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1134\/S1990747818040074","article-title":"Cationic liposomes cause ros generation and release of neutrophil extracellular traps","volume":"13","author":"Lotosh","year":"2019","journal-title":"Biochemistry (Moscow) Suppl. Series a: Membr. Cell Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107294_b0140","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2008.05.005","article-title":"Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine","volume":"130","author":"Yan","year":"2008","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107294_b0145","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/ijc.20452","article-title":"Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells","volume":"112","author":"Banerjee","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bioorg.2024.107294_b0150","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1080\/17435390.2019.1643049","article-title":"Efficient anti-tumor nano-lipoplexes with unsaturated or saturated lipid induce differential genotoxic effects in mice","volume":"13","author":"Rachamalla","year":"2019","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.bioorg.2024.107294_b0155","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.biochi.2022.02.003","article-title":"Vimentin: regulation and pathogenesis","volume":"197","author":"Paulin","year":"2022","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107294_b0160","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/cdd.2017.169","article-title":"How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?","volume":"25","author":"Aubrey","year":"2018","journal-title":"Cell Death Differ."},{"issue":"5660","key":"10.1016\/j.bioorg.2024.107294_b0165","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1092734","article-title":"Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis","volume":"303","author":"Chipuk","year":"2004","journal-title":"Science"},{"issue":"344","key":"10.1016\/j.bioorg.2024.107294_b0170","doi-asserted-by":"crossref","first-page":"p. re8-re8","DOI":"10.1126\/scisignal.2005189","article-title":"Signaling mechanisms of the epithelial-mesenchymal transition","volume":"7","author":"Gonzalez","year":"2014","journal-title":"Sci. Signal."},{"issue":"34","key":"10.1016\/j.bioorg.2024.107294_b0175","doi-asserted-by":"crossref","first-page":"22825","DOI":"10.1074\/jbc.M109.023960","article-title":"Reversibility of epithelial-mesenchymal transition (EMT) induced in breast cancer cells by activation of urokinase receptor-dependent cell signaling","volume":"284","author":"Jo","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107294_b0180","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.biochi.2019.08.003","article-title":"Role of AKT and mTOR signaling pathways in the induction of epithelial-mesenchymal transition (EMT) process","volume":"165","author":"Roshan","year":"2019","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107294_b0185","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioorg.2024.107294_b0190","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.steroids.2016.02.019","article-title":"New dimension of glucocorticoids in cancer treatment","volume":"111","author":"Lin","year":"2016","journal-title":"Steroids"},{"key":"10.1016\/j.bioorg.2024.107294_b0195","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3389\/fimmu.2019.01545","article-title":"A general introduction to glucocorticoid biology","volume":"10","author":"Timmermans","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2024.107294_b0200","doi-asserted-by":"crossref","unstructured":"Pufall, M.A., Glucocorticoids and cancer. Glucocorticoid Signaling: From Molecules to Mice to Man, 2015: p. 315-333.","DOI":"10.1007\/978-1-4939-2895-8_14"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107294_b0205","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1021\/acs.molpharmaceut.0c01091","article-title":"Self-assembling derivative of hydrocortisone as glucocorticoid receptor-targeted nanotherapeutics for synergistic, combination therapy against colorectal tumor","volume":"18","author":"Sridharan","year":"2020","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107294_b0210","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5114\/pg.2018.81072","article-title":"Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors","volume":"14","author":"Rawla","year":"2019","journal-title":"Gastroenterol. Rev.\/Przegl\u0105d Gastroenterologiczny"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107294_b0215","doi-asserted-by":"crossref","first-page":"11257","DOI":"10.1038\/s41598-019-47696-2","article-title":"Increased glucocorticoid receptor activity and proliferation in metastatic colon cancer","volume":"9","author":"Tian","year":"2019","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bioorg.2024.107294_b0220","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.1039\/c4nr00974f","article-title":"Cancer cell-selective promoter recognition accompanies antitumor effect by glucocorticoid receptor-targeted gold nanoparticle","volume":"6","author":"Sau","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.bioorg.2024.107294_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109072","article-title":"A nuclear targeted dox-aptamer loaded liposome delivery platform for the circumvention of drug resistance in breast cancer","volume":"117","author":"Li","year":"2019","journal-title":"Biomed. Pharmacother."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824001998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824001998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T15:24:53Z","timestamp":1712676293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824001998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":45,"alternative-id":["S0045206824001998"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107294","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bis-arylidene oxindoles for colorectal cancer nanotherapy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107294","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107294"}}